PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 15, 2026Future Journal of Pharmaceutical Sciences0 citationsOpen Access

Assessing the genetic contribution of certain GAS6/AXL variants to diabetic kidney disease susceptibility in Egyptian patients: a case–control observational study

View Full Paper
TMTarek Kamal MotawiDSDina SabryNANancy Mamdouh Ahmed

Key Points

  • The study aimed to evaluate the link between GAS6/AXL genetic variants and the risk of diabetic kidney disease in Egyptians.
  • Genotyping of GAS6 and AXL SNPs in type 2 diabetic patients and healthy controls
  • Comparison of genotypic frequencies among groups using Hardy-Weinberg equilibrium
  • Assessment of plasma GAS6 and AXL levels using ELISA
  • Statistical analysis of SNP associations with kidney disease
  • No significant differences in genotypic frequencies for the analyzed SNPs between cases and controls
  • SNP variations did not impact plasma GAS6 or AXL levels
  • Study found no significant association with type 2 diabetes or DKD development

Abstract

Abstract Background Diabetic kidney disease (DKD) denotes the structural and functional alterations in renal tissues occurring as a diabetic complication. Growth arrest-specific 6 (GAS6) and its receptor AXL have been identified as biological markers linked to DKD. Single nucleotide polymorphisms (SNPs) serve as valuable markers for assessing polygenic diseases like DKD. This study investigated the association of GAS6 rs8191974, rs9577873, AXL rs2304232, and rs4802113 with DKD in Egyptians. Methods SNP selection was based on previous literature, and potential functional impact according to Ensembl Variant Effect Predictor. The SNPs were genotyped in 70 type 2 diabetic patients with normal kidney functions and diabetic duration > 5 years as the DM group, 70 type 2 diabetic patients showing microalbuminuria (30–300 mg/day) as the DKD group, and 60 apparently healthy controls, using TaqMan genotyping assays. Glycosylated hemoglobin, plasma creatinine and fasting plasma glucose levels were determined spectrophotometrically. Urinary albumin, plasma GAS6 and AXL levels were assayed using ELISA kits. Results Genotyping of the SNPs in cases and controls fitted the Hardy–Weinberg equilibrium ( p > 0.05). The genotypic frequencies as compared between cases and controls for rs8191974 ( p = 0.609, χ 2 = 2.703), rs9577873 ( p = 0.916, χ 2 = 4.611), rs2304232 ( p = 0.215, χ 2 = 5.799) and rs4802113 ( p = 0.742, χ 2 = 6.828) revealed no statistically significant differences. Genotypic variation in the analyzed SNPs within each group did not influence plasma GAS6 or AXL levels. No significant associations were noticed between studied parameters and SNP alleles. Conclusion No significant association was found between GAS6 rs8191974, GAS6 rs9577873, AXL rs2304232, or AXL rs4802113 and the development of type 2 diabetes or DKD in Egyptians. To date, this is the first genetic study assessing GAS6/AXL gene variants association with DKD in the Egyptian population.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Motawi et al. (2026) studied this question.

synapsesocial.com/papers/69df2bece4eeef8a2a6b0e7fhttps://doi.org/10.1186/s43094-026-00975-y
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The Level of Serum Albumin Is Associated with Renal Prognosis in Patients with Diabetic Nephropathy2019 · 121 citations
  2. 2The growth arrest-specific 6 (Gas6) gene polymorphism c.834+7G>A is associated with type 2 diabetes2011 · 30 citations
  3. 3Tyro3 is a podocyte protective factor in glomerular disease2018 · 28 citations
  4. 4Triallelic Single Nucleotide Polymorphisms and Genotyping Error in Genetic Epidemiology Studies:MDR1(ABCB1)G2677/T/Aas an Example2007 · 63 citations
  5. 5Transcriptomic analysis reveals partial epithelial–mesenchymal transition and inflammation as common pathogenic mechanisms in hypertensive nephrosclerosis and Type 2 diabetic nephropathy2023 · 12 citations